Apex Medical Corp. (4106.TW)

TWD 24.5

(1.24%)

EBITDA Summary of Apex Medical Corp.

  • Apex Medical Corp.'s latest annual EBITDA in 2023 was 318.12 Million TWD , up 4.07% from previous year.
  • Apex Medical Corp.'s latest quarterly EBITDA in 2024 Q2 was 52.64 Million TWD , down -26.39% from previous quarter.
  • Apex Medical Corp. reported an annual EBITDA of 305.21 Million TWD in 2022, up 27.71% from previous year.
  • Apex Medical Corp. reported an annual EBITDA of 238.98 Million TWD in 2021, up 13.11% from previous year.
  • Apex Medical Corp. reported a quarterly EBITDA of 52.64 Million TWD for 2024 Q2, down -26.39% from previous quarter.
  • Apex Medical Corp. reported a quarterly EBITDA of 64.69 Million TWD for 2023 Q3, down -36.15% from previous quarter.

Annual EBITDA Chart of Apex Medical Corp. (2023 - 2009)

Historical Annual EBITDA of Apex Medical Corp. (2023 - 2009)

Year EBITDA EBITDA Growth
2023 318.12 Million TWD 4.07%
2022 305.21 Million TWD 27.71%
2021 238.98 Million TWD 13.11%
2020 211.28 Million TWD -9.31%
2019 232.96 Million TWD 4.99%
2018 226.13 Million TWD -6.34%
2017 250.94 Million TWD -8.94%
2016 272.53 Million TWD -21.31%
2015 330.65 Million TWD -9.26%
2014 364.4 Million TWD 17.13%
2013 311.45 Million TWD -5.47%
2012 319.74 Million TWD 5.01%
2011 285.84 Million TWD 14.71%
2010 240.84 Million TWD -15.48%
2009 309.26 Million TWD 0.0%

Peer EBITDA Comparison of Apex Medical Corp.

Name EBITDA EBITDA Difference
Excelsior Medical Co., Ltd. 968.55 Million TWD 67.155%
OK Biotech Co., Ltd. 87.24 Million TWD -264.636%
Applied BioCode Corporation -98.59 Million TWD 422.669%